Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Nafronyl oxalate salt

Nafronyl oxalate salt

3200-06-4

DISCOVER
NEOSTIGMINE BROMIDE CRS (50 MG)

NEOSTIGMINE BROMIDE CRS (50 MG)

114-80-7

DISCOVER
Norfloxacin D5

Norfloxacin D5

1015856-57-1

DISCOVER
Norfloxacin

Norfloxacin

70458-96-7

DISCOVER
NEOSTIGMINE METILSULFATE CRS (50 MG)

NEOSTIGMINE METILSULFATE CRS (50 MG)

51-60-5

DISCOVER
NETILMICIN SULFATE CRS (25 MG)

NETILMICIN SULFATE CRS (25 MG)

56391-57-2

DISCOVER
NICLOSAMIDE (ANHYDROUS) CRS (50 MG)

NICLOSAMIDE (ANHYDROUS) CRS (50 MG)

50-65-7

DISCOVER
NICOTINE - REFERENCE SPECTRUM(N/A)

NICOTINE - REFERENCE SPECTRUM(N/A)

NA

DISCOVER
NICOTINE DITARTRATE CRS (120 MG)

NICOTINE DITARTRATE CRS (120 MG)

65-31-6

DISCOVER
NICOTINAMIDE CRS (50 MG)

NICOTINAMIDE CRS (50 MG)

98-92-0

DISCOVER
Norpseudoephedrine HCl

Norpseudoephedrine HCl

2153-98-2

DISCOVER
NICOTINIC ACID CRS (100 MG)

NICOTINIC ACID CRS (100 MG)

59-67-6

DISCOVER